Clinical Study
A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, a Commiphora myrrha Extract with a High Furanodiene Content
Table 1
Furanodiene content of MyrLiq. Data are expressed as the relative area percentage and content (standard deviation).
| Compound | Furanodiene area percentage | Content (g kg−1) |
| Curzerene | 17.93 (0.20) | 12.31 (0.05) | Furanoeudesma-1,3-diene | 27.44 (0.17) | 18.84 (0.02) | Lindestrene | 9.08 (0.06) | 6.23 (0.01) | Unknown furanodiene (MW = 216) | 0.44 (0.01) | 0.30 (0.004) | Dihydrolinderalactone | 1.91 (0.02) | 1.31 (0.02) | Acetoxy-furanodiene (MW = 274) | 0.87 (0.05) | 0.59 (0.03) | Acetoxy-furanodiene (MW = 232) | 1.85 (0.04) | 1.27 (0.03) | Total | 59.51 (0.43) | 40.86 (0.78) |
|
|